Etanercept for active Crohn’s disease: A randomized, double-blind, placebo-controlled trial

William J. Sandborn, Stephen B. Hanauer, Seymour Katz, Michael Safdi, Douglas G. Wolf, Richard D. Baerg, William J. Tremaine, Therese Johnson, Nancy N. Diehl, Alan R. Zinsmeister

Research output: Contribution to journalArticlepeer-review

780 Scopus citations

Fingerprint

Dive into the research topics of 'Etanercept for active Crohn’s disease: A randomized, double-blind, placebo-controlled trial'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science